Press time:2016-11-18From:CR Pharma [ Font:BigMediumSmall]
China Resources (Holdings) Co. Ltd. (“CRH”) and FUJIFILM Holdings Corporation (“FH”) announced that CRH and FH have entered into a non-legally binding agreement (“Agreement”) to establish a business alliance (“Alliance”). Under the Agreement, CRH and FH will work together to jointly pursue potential business opportunities in various areas including the healthcare sector, which covers:
1.Distribution of consumable products and services of FH in China through the distribution network of CRH and its subsidiaries
2.Business development of pharmaceutical products including biosimilars, regenerative medicine products and medical equipment devices products in China
3.Exploration of the feasibility of Traditional Chinese medicine upgrade and global sales
4.Introduction of high-end medical services to China with reference to the medical service offered in Japan
CRH is the controlling shareholder of China Resources Pharmaceutical Group Limited (the “Company”) that is one of the largest integrated pharmaceutical companies in China with leading positions in manufacturing, distribution and retail segments. FH is the holding company of Fujifilm Corporation that is a cornerstone investor of the Company’s Global Offering in October 2016, which has been actively expanding into the healthcare business. The formation of this Alliance does not only bring two of the Asian’s largest corporations together to explore business opportunities in the healthcare sector, but also will help further strengthen the Company’s leading position in the sector.
